Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape.

Hegde M, Mukherjee M, Grada Z, Pignata A, Landi D, Navai SA, Wakefield A, Fousek K, Bielamowicz K, Chow KK, Brawley VS, Byrd TT, Krebs S, Gottschalk S, Wels WS, Baker ML, Dotti G, Mamonkin M, Brenner MK, Orange JS, Ahmed N.

J Clin Invest. 2019 Jul 2;129(8):3464. doi: 10.1172/JCI131246. eCollection 2019 Jul 2. No abstract available.

2.

Adoptive Cell Therapy for Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia.

Lulla PD, Mamonkin M, Brenner MK.

Cancer J. 2019 May/Jun;25(3):199-207. doi: 10.1097/PPO.0000000000000376.

PMID:
31135527
3.

Chimeric Antigen Receptors for T-Cell Malignancies.

Scherer LD, Brenner MK, Mamonkin M.

Front Oncol. 2019 Mar 5;9:126. doi: 10.3389/fonc.2019.00126. eCollection 2019. Review.

4.

Retraction Note: A homing system targets therapeutic T cells to brain cancer.

Samaha H, Pignata A, Fousek K, Ren J, Lam FW, Stossi F, Dubrulle J, Salsman VS, Krishnan S, Hong SH, Baker ML, Shree A, Gad AZ, Shum T, Fukumura D, Byrd TT, Mukherjee M, Marrelli SP, Orange JS, Joseph SK, Sorensen PH, Taylor MD, Hegde M, Mamonkin M, Jain RK, El-Naggar S, Ahmed N.

Nature. 2019 Mar;567(7746):132. doi: 10.1038/s41586-019-0967-z.

5.

CD7 CAR T Cells for the Therapy of Acute Myeloid Leukemia.

Gomes-Silva D, Atilla E, Atilla PA, Mo F, Tashiro H, Srinivasan M, Lulla P, Rouce RH, Cabral JMS, Ramos CA, Brenner MK, Mamonkin M.

Mol Ther. 2019 Jan 2;27(1):272-280. doi: 10.1016/j.ymthe.2018.10.001. Epub 2018 Oct 4.

PMID:
30391141
6.

A homing system targets therapeutic T cells to brain cancer.

Samaha H, Pignata A, Fousek K, Ren J, Lam FW, Stossi F, Dubrulle J, Salsman VS, Krishnan S, Hong SH, Baker ML, Shree A, Gad AZ, Shum T, Fukumura D, Byrd TT, Mukherjee M, Marrelli SP, Orange JS, Joseph SK, Sorensen PH, Taylor MD, Hegde M, Mamonkin M, Jain RK, El-Naggar S, Ahmed N.

Nature. 2018 Sep;561(7723):331-337. doi: 10.1038/s41586-018-0499-y. Epub 2018 Sep 5. Retraction in: Nature. 2019 Mar;567(7746):132.

7.

Reversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-cell Malignancies.

Mamonkin M, Mukherjee M, Srinivasan M, Sharma S, Gomes-Silva D, Mo F, Krenciute G, Orange JS, Brenner MK.

Cancer Immunol Res. 2018 Jan;6(1):47-58. doi: 10.1158/2326-6066.CIR-17-0126. Epub 2017 Oct 27.

8.

Tonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-Dependent.

Gomes-Silva D, Mukherjee M, Srinivasan M, Krenciute G, Dakhova O, Zheng Y, Cabral JMS, Rooney CM, Orange JS, Brenner MK, Mamonkin M.

Cell Rep. 2017 Oct 3;21(1):17-26. doi: 10.1016/j.celrep.2017.09.015.

9.

Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1.

Tashiro H, Sauer T, Shum T, Parikh K, Mamonkin M, Omer B, Rouce RH, Lulla P, Rooney CM, Gottschalk S, Brenner MK.

Mol Ther. 2017 Sep 6;25(9):2202-2213. doi: 10.1016/j.ymthe.2017.05.024. Epub 2017 Jul 1.

10.

Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody-Activated Chimeric Antigen Receptor-Modified T Cells.

Schmueck-Henneresse M, Omer B, Shum T, Tashiro H, Mamonkin M, Lapteva N, Sharma S, Rollins L, Dotti G, Reinke P, Volk HD, Rooney CM.

J Immunol. 2017 Jul 1;199(1):348-362. doi: 10.4049/jimmunol.1601494. Epub 2017 May 26.

11.

CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies.

Gomes-Silva D, Srinivasan M, Sharma S, Lee CM, Wagner DL, Davis TH, Rouce RH, Bao G, Brenner MK, Mamonkin M.

Blood. 2017 Jul 20;130(3):285-296. doi: 10.1182/blood-2017-01-761320. Epub 2017 May 24.

12.

[CAR T-cell therapy: Balance of efficacy and safety].

Kulemzin SV, Kuznetsova VV, Mamonkin M, Taranin AV, Gorchakov AA.

Mol Biol (Mosk). 2017 Mar-Apr;51(2):274-287. doi: 10.7868/S0026898417020148. Review. Russian.

13.

Engineering Chimeric Antigen Receptors.

Kulemzin SV, Kuznetsova VV, Mamonkin M, Taranin AV, Gorchakov AA.

Acta Naturae. 2017 Jan-Mar;9(1):6-14.

14.

Exhausting alloreactivity of donor-derived CAR T cells.

Mamonkin M, Heslop HE.

Nat Med. 2017 Feb 7;23(2):147-148. doi: 10.1038/nm.4276. No abstract available.

PMID:
28170385
15.

Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape.

Hegde M, Mukherjee M, Grada Z, Pignata A, Landi D, Navai SA, Wakefield A, Fousek K, Bielamowicz K, Chow KK, Brawley VS, Byrd TT, Krebs S, Gottschalk S, Wels WS, Baker ML, Dotti G, Mamonkin M, Brenner MK, Orange JS, Ahmed N.

J Clin Invest. 2016 Aug 1;126(8):3036-52. doi: 10.1172/JCI83416. Epub 2016 Jul 18.

16.

A T-cell-directed chimeric antigen receptor for the selective treatment of T-cell malignancies.

Mamonkin M, Rouce RH, Tashiro H, Brenner MK.

Blood. 2015 Aug 20;126(8):983-92. doi: 10.1182/blood-2015-02-629527. Epub 2015 Jun 8.

17.

Early transduction produces highly functional chimeric antigen receptor-modified virus-specific T-cells with central memory markers: a Production Assistant for Cell Therapy (PACT) translational application.

Sun J, Huye LE, Lapteva N, Mamonkin M, Hiregange M, Ballard B, Dakhova O, Raghavan D, Durett AG, Perna SK, Omer B, Rollins LA, Leen AM, Vera JF, Dotti G, Gee AP, Brenner MK, Myers DG, Rooney CM.

J Immunother Cancer. 2015 Feb 18;3:5. doi: 10.1186/s40425-015-0049-1. eCollection 2015.

18.

Transcription factor ELF4 promotes development and function of memory CD8(+) T cells in Listeria monocytogenes infection.

Mamonkin M, Puppi M, Lacorazza HD.

Eur J Immunol. 2014 Mar;44(3):715-27. doi: 10.1002/eji.201343775. Epub 2014 Jan 13.

19.

Differential roles of KLF4 in the development and differentiation of CD8+ T cells.

Mamonkin M, Shen Y, Lee PH, Puppi M, Park CS, Lacorazza HD.

Immunol Lett. 2013 Nov-Dec;156(1-2):94-101. doi: 10.1016/j.imlet.2013.09.008. Epub 2013 Sep 25.

20.

FCRL6 receptor: expression and associated proteins.

Kulemzin SV, Zamoshnikova AY, Yurchenko MY, Vitak NY, Najakshin AM, Fayngerts SA, Chikaev NA, Reshetnikova ES, Kashirina NM, Peclo MM, Rutkevich PN, Shevelev AY, Yanushevskaya EV, Baranov KO, Mamonkin M, Vlasik TN, Sidorenko SP, Taranin AV, Mechetina LV.

Immunol Lett. 2011 Jan 30;134(2):174-82. doi: 10.1016/j.imlet.2010.09.023. Epub 2010 Oct 7.

PMID:
20933011
21.

Transcription factor ELF4 controls the proliferation and homing of CD8+ T cells via the Krüppel-like factors KLF4 and KLF2.

Yamada T, Park CS, Mamonkin M, Lacorazza HD.

Nat Immunol. 2009 Jun;10(6):618-26. doi: 10.1038/ni.1730. Epub 2009 May 3.

Supplemental Content

Loading ...
Support Center